160 related articles for article (PubMed ID: 23297753)
1. Tumor-stromal interactions in breast tumor progression--significance of histological heterogeneity of tumor-stromal fibroblasts.
Hasebe T
Expert Opin Ther Targets; 2013 Apr; 17(4):449-60. PubMed ID: 23297753
[TBL] [Abstract][Full Text] [Related]
2. Atypical tumor-stromal fibroblasts in invasive ductal carcinoma of the breast.
Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
Am J Surg Pathol; 2011 Mar; 35(3):325-36. PubMed ID: 21317705
[TBL] [Abstract][Full Text] [Related]
3. Atypical tumor-stromal fibroblasts in invasive ductal carcinomas of the breast treated with neoadjuvant therapy.
Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shimizu C; Andoh M; Fujiwara Y; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
Hum Pathol; 2011 Jul; 42(7):998-1006. PubMed ID: 21315415
[TBL] [Abstract][Full Text] [Related]
4. Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast.
Hasebe T; Sasaki S; Imoto S; Ochiai A
Mod Pathol; 2001 Apr; 14(4):325-37. PubMed ID: 11301349
[TBL] [Abstract][Full Text] [Related]
5. p53 expression in tumor-stromal fibroblasts is closely associated with the nodal metastasis and outcome of patients with invasive ductal carcinoma who received neoadjuvant therapy.
Hasebe T; Tamura N; Okada N; Hojo T; Akashi-Tanaka S; Shimizu C; Tsuda H; Shibata T; Sasajima Y; Iwasaki M; Kinoshita T
Hum Pathol; 2010 Feb; 41(2):262-70. PubMed ID: 19836055
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
[TBL] [Abstract][Full Text] [Related]
7. Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors.
Erez N; Glanz S; Raz Y; Avivi C; Barshack I
Biochem Biophys Res Commun; 2013 Aug; 437(3):397-402. PubMed ID: 23831470
[TBL] [Abstract][Full Text] [Related]
8. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
9. Loss of ALX4 expression in epithelial cells and adjacent stromal cells in breast cancer.
Chang H; Mohabir N; Done S; Hamel PA
J Clin Pathol; 2009 Oct; 62(10):908-14. PubMed ID: 19783719
[TBL] [Abstract][Full Text] [Related]
10. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome.
Iwaya K; Ogawa H; Izumi M; Kuroda M; Mukai K
Virchows Arch; 2002 Jun; 440(6):589-93. PubMed ID: 12070597
[TBL] [Abstract][Full Text] [Related]
11. Host response to human breast Invasive Ductal Carcinoma (IDC) as observed by changes in the stromal proteome.
Reddy LA; Mikesh L; Moskulak C; Harvey J; Sherman N; Zigrino P; Mauch C; Fox JW
J Proteome Res; 2014 Nov; 13(11):4739-51. PubMed ID: 25244421
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic factors significantly associated with initial organ-specific metastasis by invasive ductal carcinoma of the breast: a prospective study.
Hasebe T; Imoto S; Yokose T; Ishii G; Iwasaki M; Wada N
Hum Pathol; 2008 May; 39(5):681-93. PubMed ID: 18329692
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
14. Expression of p21waf1/Cip1 in stromal fibroblasts of primary breast tumors.
Trimis G; Chatzistamou I; Politi K; Kiaris H; Papavassiliou AG
Hum Mol Genet; 2008 Nov; 17(22):3596-600. PubMed ID: 18713757
[TBL] [Abstract][Full Text] [Related]
15. Significance of basic fibroblast growth factor and fibroblast growth factor receptor protein expression in the formation of fibrotic focus in invasive ductal carcinoma of the breast.
Hasebe T; Imoto S; Ogura T; Mukai K
Jpn J Cancer Res; 1997 Sep; 88(9):877-85. PubMed ID: 9369936
[TBL] [Abstract][Full Text] [Related]
16. Impact of different tumour stroma assessment methods regarding podoplanin expression on clinical outcome in patients with invasive ductal breast carcinoma.
Pula B; Wojnar A; Werynska B; Ambicka A; Kruczak A; Witkiewicz W; Ugorski M; Podhorska-Okolow M; Dziegiel P
Anticancer Res; 2013 Apr; 33(4):1447-55. PubMed ID: 23564785
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.
Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
Hum Pathol; 2011 Dec; 42(12):1823-32. PubMed ID: 21683981
[TBL] [Abstract][Full Text] [Related]
18. New prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus.
Hasebe T; Mukai K; Tsuda H; Ochiai A
Pathol Int; 2000 Apr; 50(4):263-72. PubMed ID: 10849311
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study.
Hasebe T; Sasaki S; Imoto S; Mukai K; Yokose T; Ochiai A
Mod Pathol; 2002 May; 15(5):502-16. PubMed ID: 12011255
[TBL] [Abstract][Full Text] [Related]
20. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
